Summary & Overview

CPT 88153: Manual Cervical/Vaginal Cytopathology Analysis and Rescreen

CPT code 88153 represents the technical laboratory procedure in which a trained lab analyst manually analyzes a cervical or vaginal cytology slide and then performs a manual rescreen of the same slide under physician supervision. This code captures a hands-on, quality-focused step in cytopathology workflows that supports accurate detection of cervical and vaginal cellular abnormalities and can affect downstream clinical management and surveillance programs nationally. Payers commonly covering services like this include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

This publication provides a concise national overview of clinical context, common billing considerations, and the service delivery settings for CPT code 88153. Readers will find benchmarks and descriptive guidance on typical sites of service, common modifiers associated with laboratory technical components, and how this service fits into cytopathology workflows. The content highlights the role of manual rescreening in quality assurance and the relevance of physician supervision for the technical component. Data not available in the input are noted where applicable; the focus remains on clear, national-level description and operational context for payers, coders, and laboratory managers.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare88153CPTcytopathologylab-technologymanual-rescreeningtechnical-componentcervical-cytologyvaginal-cytology

Billing Code Overview

CPT code 88153 describes a laboratory service in which a lab analyst performs a manual cytopathology slide analysis of a cervical or vaginal specimen and then manually rescreens the same slide, carrying out the technical component under a physician’s supervision. This service involves hands-on microscopic review and a repeat manual screening of the same cytology slide to ensure accurate detection of cellular abnormalities.

Service type: Manual cytopathology technical and rescreening service
Typical site of service: Clinical laboratory or hospital laboratory setting

Clinical & Coding Specifications

Clinical Context

A 35-year-old woman presents for routine cervical cancer screening after a pelvic exam performed by her primary care clinician. A clinician collects a cervical cytology specimen (Pap smear) and submits the slide to an outpatient clinical laboratory. A cytology technologist (lab analyst) performs a manual microscopic evaluation of the cervical slide, documents findings, and then performs a second, independent manual rescreen of the same slide under the supervising pathologist's direction to ensure quality and detection of rare abnormal cells. The supervising pathologist reviews any flagged or abnormal findings and signs the final report. Typical sites of service include hospital-based pathology laboratories, independent clinical pathology labs, and large outpatient diagnostic laboratories supporting ambulatory clinics.

Service Type: Laboratory technical cytology service with manual rescreening of a cervical or vaginal cytopathology slide.
Typical Site of Service: Hospital clinical laboratory, independent diagnostic laboratory, outpatient pathology laboratory.
Typical Patient Scenario: Asymptomatic screening or follow-up of prior abnormal cytology; specimen processed manually due to slide quality or when automated screening is not available or when a quality-control rescreen is required. The lab analyst documents results and escalates abnormal or indeterminate findings for physician review.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When reporting the physician component of a split-service cytology interpretation performed by the pathologist separate from lab technical work.
`TC`	Technical component	When billing only the laboratory technical component performed by the facility or non-physician lab personnel.
`90`	Reference (outside) laboratory	When the test was performed by an outside/reference laboratory and the billing entity is reporting payer-required reference testing.
`80`	Assistant surgeon	Rarely applicable; used when an assistant (qualified person) assists with a procedure when assistant billing is permitted. Typically not used for cytology but included for completeness when applicable.
`82`	Assistant (when qualified resident not available)	Used when assistant services are provided and the usual resident assistant waiver does not apply; rarely used for cytology workflows.
`11`	Surgical care only	When only a portion of global services are provided; relevant if the lab service relates to a bundled procedure and only surgical portion is reported separately.
`22`	Increased procedural services	When unusually complex lab processing or additional work justifies increased reimbursement; documentation must justify unusual effort.
`52`	Reduced services	When the service provided is reduced or partially performed compared with full code definition.
`53`	Discontinued procedure	When the laboratory procedure was started but discontinued for reasons related to patient condition or specimen unsuitability.
`59`	Distinct procedural service	Use to indicate a separate and distinct service when needed to report multiple lab services on the same day (Note: `59` is not in the provided list; not used).

Taxonomy Code	Specialty	Notes
207RP1000X	Anatomic and Clinical Pathology	Pathologists who supervise cytology and interpret abnormal slides.
208000000X	Pathology	General pathology providers involved in slide review and sign-out.
174C00000X	Diagnostic Laboratory	Clinical laboratory professionals and lab directors overseeing technical cytology services.
363L00000X	Clinical Cytogenetics Laboratory	Laboratory specialists involved in cytologic testing workflows and quality control.
173E00000X	Laboratory Technologist/Technician	Cytology technologists and lab analysts who perform manual screening and rescreening.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N87.0`	Mild cervical dysplasia (CIN I)	Common abnormal screening result prompting cytology review and potential rescreening for quality assurance.
`N87.1`	Moderate cervical dysplasia (CIN II)	Abnormal finding on Pap that requires careful cytologic evaluation and confirmatory review.
`N87.2`	Severe cervical dysplasia (CIN III)	High-grade cytologic abnormality often requiring confirmatory cytology and pathology correlation.
`R87.619`	Abnormal cytology of cervix, unspecified	Used to report abnormal cervical cytology findings that led to additional laboratory review or rescreening.
`Z12.4`	Encounter for screening for malignant neoplasm of cervix	Common reason for Pap testing where manual screening and rescreening services are performed.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`88152`	Cytopathology, cervical or vaginal (Pap), smear; requiring interpretation by physician with manual screening by technologist (first review)	Often billed for the initial manual screening step when a technologist performs the primary review prior to rescreening; `88153` represents the rescreening by the technologist.
`88164`	Cytopathology, cervical or vaginal (Pap), requiring interpretation by physician with automated screening, and manual rescreening by technologist	Related when automated primary screening is used; `88164` covers automated screen with manual rescreen, whereas `88153` covers manual rescreen following a manual initial screen.
`88141`	Cytopathology, cervical or vaginal (Pap), requiring interpretation by a physician, single smear; physician interpretation without technologist rescreen	Represents the physician-only interpretation option when technologist screening/rescreening is not performed.
`88150`	Cytopathology, cervical or vaginal (Pap), screening by automated system, unlisted if manual rescreen not required	Used in workflows that begin with automated screening rather than manual; helps differentiate method used.
`88174`	Cytopathology, slides prepared and sent for review; ancillary CPT for review of non-gynecologic cytology	May be used for additional slide preparations or consultations in complex cytology cases following initial and rescreening steps.